SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter Lüttge Jordal, Thomas F Dyrlund, Kristian Winge, Martin R Larsen, Erik H Danielsen, James A Wells, Daniel E Otzen, Jan J Enghild, Detection of proteolytic signatures for Parkinson's disease, Future Neurology, 2016, 11, 1, 15

    CrossRef

  2. 2
    Samantha K. Holden, Wallace E. Jones, Keith A. Baker, Isabel M. Boersma, Benzi M. Kluger, Outcome Measures for Parkinson's Disease Dementia: A Systematic Review, Movement Disorders Clinical Practice, 2016, 3, 1
  3. 3
    Wei-Ju Lee, Shey-Lin Wu, Jie-Yuan Li, Chin-Chung Chen, Juei-Jueng Lin, Giia-Sheun Peng, Tsu-Kung Lin, Shuu-Jiun Wang, Rou-Shayn Chen, Yuan-Han Yang, Chon-Haw Tsai, Jung-Lung Hsu, Yi-Chu Liao, Shih-Pin Chen, Jong-Ling Fuh, PDD-5S: A useful screening tool for Parkinson's disease dementia, Parkinsonism & Related Disorders, 2016, 25, 85

    CrossRef

  4. 4
    Marcos Serrano-Dueñas, Maite Serrano, Diana Villena, David Granda, Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease, Movement Disorders Clinical Practice, 2016, 3, 2
  5. 5
    Guiomar Nascimento Oliveira, Carolina Pinto Souza, Maria Paula Foss, Vitor Tumas, An analysis of the cognitive items of the movement disorders society checklist for the diagnosis of dementia in patients with Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 10, 1260

    CrossRef

  6. 6
    Jeremy Cosgrove, Jane Elizabeth Alty, Stuart Jamieson, Cognitive impairment in Parkinson's disease, Postgraduate Medical Journal, 2015, 91, 1074, 212

    CrossRef

  7. 7
    Nicolas Auzou, Kathy Dujardin, Roberta Biundo, Alexandra Foubert-Samier, Caroline Barth, Fanny Duval, François Tison, Luc Defebvre, Angelo Antonini, Wassilios G. Meissner, Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia, Parkinsonism & Related Disorders, 2015, 21, 10, 1273

    CrossRef

  8. 8
    Sonia Benítez-Rivero, María J. Lama, Ismael Huertas-Fernández, Paloma Álvarez de Toledo, María T. Cáceres-Redondo, Juan F. Martín-Rodríguez, Fátima Carrillo, Manuel Carballo, Francisco J. Palomar, Pablo Mir, Clinical features and neuropsychological profile in vascular parkinsonism, Journal of the Neurological Sciences, 2014, 345, 1-2, 193

    CrossRef

  9. 9
    Brandon R. Barton, Bryan Bernard, Virginie Czernecki, Jennifer G. Goldman, Glenn Stebbins, Bruno Dubois, Christopher G. Goetz, Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing, Movement Disorders, 2014, 29, 10
  10. 10
    Colette Walter, Nancy E. Edwards, Rosanne Griggs, Karen Yehle, Differentiating Alzheimer Disease, Lewy Body, and Parkinson Dementia Using DSM-5, The Journal for Nurse Practitioners, 2014, 10, 4, 262

    CrossRef

  11. 11
    Meike Kasten, Eva-Juliane Vollstedt, Christine Klein, Frühsymptome und neuropsychiatrische Symptome bei der Parkinson-Erkrankung, Zeitschrift für Neuropsychologie, 2014, 25, 1, 31

    CrossRef

  12. 12
    Daniel J. Burdick, Brenna Cholerton, G.S. Watson, Andrew Siderowf, John Q. Trojanowski, Daniel Weintraub, Beate Ritz, Shannon L. Rhodes, Renecca Rausch, Stewart A. Factor, Cathy Wood-Siverio, Joseph F. Quinn, Kathryn A. Chung, Sindhu Srivatsal, Karen L. Edwards, Thomas J. Montine, Cyrus P. Zabetian, James B. Leverenz, People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance, Movement Disorders, 2014, 29, 10
  13. 13
    Michele T. M. Hu, Konrad Szewczyk-Królikowski, Paul Tomlinson, Kannan Nithi, Michal Rolinski, Clara Murray, Kevin Talbot, Klaus P. Ebmeier, Clare E. Mackay, Yoav Ben-Shlomo, Predictors of cognitive impairment in an early stage Parkinson's disease cohort, Movement Disorders, 2014, 29, 3
  14. 14
    Isabel González-Aramburu, Pascual Sánchez-Juan, María Sierra, Eduardo Fernández-Juan, Coro Sánchez-Quintana, José Berciano, Onofre Combarros, Jon Infante, Serum uric acid and risk of dementia in Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 6, 637

    CrossRef

  15. 15
    V. Isella, C. Mapelli, C. Siri, D. De Gaspari, G. Pezzoli, A. Antonini, M. Poletti, U. Bonuccelli, M. Vista, I.M. Appollonio, Validation and attempts of revision of the MDS-recommended tests for the screening of Parkinson's disease dementia, Parkinsonism & Related Disorders, 2014, 20, 1, 32

    CrossRef

  16. 16
    S. Lesage, I. Le Ber, C. Condroyer, E. Broussolle, A. Gabelle, S. Thobois, F. Pasquier, K. Mondon, P. A. Dion, D. Rochefort, G. A. Rouleau, A. Durr, A. Brice, C9orf72 repeat expansions are a rare genetic cause of parkinsonism, Brain, 2013, 136, 2, 385

    CrossRef

  17. 17
    Yue Huang, Glenda Halliday, Can we clinically diagnose dementia with Lewy bodies yet?, Translational Neurodegeneration, 2013, 2, 1, 4

    CrossRef

  18. 18
    Pablo Martinez-Martin, Dementia in Parkinson's disease: Usefulness of the pill questionnaire, Movement Disorders, 2013, 28, 13
  19. 19
    Michèle Kiesmann, Jean-Baptiste Chanson, Julien Godet, Thomas Vogel, Laetitia Schweiger, Saïd Chayer, Georges Kaltenbach, The Movement Disorders Society criteria for the diagnosis of Parkinson’s disease dementia: their usefulness and limitations in elderly patients, Journal of Neurology, 2013, 260, 10, 2569

    CrossRef

  20. 20
    Kurt A Jellinger, Neurobiology of cognitive impairment in Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1451

    CrossRef